Navigation Links
Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency
Date:9/10/2007

CHICAGO, Sept. 10 /PRNewswire-USNewswire/ -- The Blue Cross and Blue Shield Association (BCBSA), in collaboration with the Harvard Medical School's Department of Health Care Policy, announced today seven Blue Cross and Blue Shield company initiatives as 2007 BlueWorks(R) winners, in the category of 'Collaborating with Providers.'

BlueWorks is a partnership between BCBSA and the Harvard Medical School Department of Health Care Policy that recognizes the innovative ways Blue Cross and Blue Shield companies are working with doctors and hospitals to increase the efficiency and consistency of care delivery nationwide. Harvard researchers evaluate Blue Cross and Blue Shield local programs on innovation, efficacy, robust design and the potential for program replication. Since 2004, Harvard Medical School's Department of Health Care Policy has named 39 Blue Cross and Blue Shield programs as BlueWorks winners.

The 2007 BlueWorks winners are being recognized during BCBSA's BlueWorks for Providers Week (Sept. 10-14). "The 2007 BlueWorks winners are to be congratulated for designing and implementing programs to improve patient safety and efficiency," said Scott P. Serota, BCBSA president and CEO. "The BlueWorks program allows Blue Cross and Blue Shield companies to share best-practices and ultimately transform the way healthcare is delivered across America."

"We are pleased to work with the Blue Cross and Blue Shield companies as they are committed to collaborating with providers to improve the quality and delivery of care in the U.S.," said Barbara McNeil, M.D., Ph.D., head of the Department of Health Care Policy, Harvard Medical School.

The following BlueWorks winning programs exemplify the Blues' commitment to collaborating with and rewarding local healthcare providers that improve the quality of healthcare and patient safety.

Hospital Patient Safety

In 2003, Anthem Blue Cross and Blue Shield in Virginia launched their quality
'/>"/>

SOURCE Blue Cross Blue Shield Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Memory problem? solve a crossword
2. FDA attacks American Red Cross for blood violations
3. Encephalitis Death Toll In U.P. Crosses 200 Mark.
4. Encephalitis Deaths Cross 220 in Uttar Pradesh
5. Flu-Drugs Are Causing Resistance Across The World
6. Condom Vending Machines To Be Installed Across Indian States
7. First Crossover Kidney Transplantation In Germany
8. Bird Flu Infection Of Chinese Girl Prompts Fear Of Spread Across Asia
9. Chicken pox Spreads Across Firozabad
10. The Cleveland Clinic Expands Its Services across the World via the Net
11. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)... July 23 /PRNewswire-FirstCall/ - Cardiome Pharma ... it has entered into an,agreement with CR Intrinsi...CR Intrinsic Investors, LLC, an affiliate of S.A.C...rtible preferred shares for gross proceeds of,US$2...for general corporate,purposes, costs associated w...
(Date:7/23/2008)...DNA to create faster, smaller, and more powerful c...scrambling to develop successful ways to use genet...professor at Rensselaer Polytechnic Institute sugg...tations, all we have to do is literally look aroun...rk Changizi has begun to develop a technique to tu...
(Date:7/23/2008)...-USNewswire/ -- The Children,s,Hospital of Philade...ion,gift that will enable the opening of a new ped...is gift, made possible by Athena and Nicholas,Kara... in the history of,Children,s Hospital and will gi...communities convenient access to world-class pedia...
(Date:7/23/2008)... Times may be tough, but,Hollywood,s young stars l...a dazzling new smile to boost confidence. Cosmetic...ty clients beam in on success, citing his,experien...confidence they,need for stardom. In agreement is ...ge smile designed by Dr. Kosdon., MTV,s Rock The ...
Breaking Medicine News(10 mins):Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:Study suggests human visual system could make powerful computer 2Health News:Study suggests human visual system could make powerful computer 3Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2
...ueen Kate Moss has confided to Sir Richard Branso... the media about her cocaine addiction. // Richar...te Moss is very close to him and he has known her ...reer in 1999. She said to him that it made her fac...
...elbourne and La Trobe University have identified t...ins such as wheat and barley. With the stress bein...rchers fell that this discovery would allow them t... The genes are important in the production of bet...
... soon go on Phase I trial. It maybe as early as a ...ar Shaw. Ms.Shaw was speaking at the conference ...oundation(MDRF) on awards for innovation and R&D./...ics in India and any research related to diabetes ...
...e-changing operation in India and returned home sa...vice (NHS), for being// overweight. David Rogers,...he NHS that he was too overweight for the double h...tely needed. Weighing almost 140 kg, he was told t...
Other Medicine News:Health News:Overweight Briton Underwent Successful Surgery In India Being Denied By NHS 2
(Date:7/22/2008)...y 22 /- Following a,thoroug...of Progen,Pharmaceuticals Limited (ASX: PGL; Nasda...the PI-88 phase 3 study in liver cancer. Progen co...sting portfolio of compounds and,the company will ...opportunities through Merger & Acquisition activit...
(Date:7/22/2008)...s Development Plan Completed Successfully, DUBLIN...n Corporation,plc (NASDAQ: AMRN ) today announced...he U.S. Food and Drug Administration (FDA) to disc...treatment of,hypertriglyceridemia. Following these... with AMR101 in hypertriglyceridemia., Dr. Declan...
(Date:7/22/2008)...tress the Importance to Patients of Passing a ... RICHMOND, Va., July 22 /-...ow-on biologics and biopharmaceuticals, today,anno...ill present at a,Congressional briefing on Friday,...or establishing an approval pathway for follow-on,...
(Date:7/22/2008)...ve Laser Lipolysis Technology in the European ...., July 22 /- Cynosure, Inc...cturer of a broad array of,light-based aesthetic t...k,for Smartlipo MPX(TM), the company,s high-powere...y fat and tighten skin through collagen,remodeling...
Breaking Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3Immunotec Inc announces appointment of President 26 CEO James A Northrop 1219 1Immunotec Inc announces appointment of President 26 CEO James A Northrop 1219 2PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 500 1PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 500 2PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 500 3PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 500 4 242 7 million awarded for metastatic colon cancer research 771 1 242 7 million awarded for metastatic colon cancer research 771 2 242 7 million awarded for metastatic colon cancer research 771 3Nanoparticle exposures happen says expert 769 1Nanoparticle exposures happen says expert 769 2
Basic-level interpretive resting ECG
XALATAN is a prescription medicine used to lower eye pressure, also called intraocular pressure, or IOP, in patients with ocular hypertension (abnormally high IOP) or open-angle glaucoma.
The ECG-9010 meets IEC60601-2-51 new international standard for digital electrocardiographs specifying accuracy and digital filter performance. ECG data can be reviewed and managed on a Windows PC wi
The UltraVac V1 allows for unprecedented chamber stability and high vacuum levels with venturi systems. Vacuum and flow are proportionately linked on a venturi pump and cannot be independently adjust
Medicine Products: